Quest Diagnostics Inc (NYSE:DGX)
| 140.43 Delayed Data As of 4:01pm ET |  +3.01 / +2.19%Today’s Change | 125.33 Today|||52-Week Range 174.16 | -18.83% Year-to-Date |
Latest DGX News | Press Releases
| Is Quest Diagnostics (DGX) a Great Value Stock Right Now? Jun 23 / Zacks.com - Paid Partner Content | Here's Why You Should Hold Quest Diagnostics (DGX) Stock Now Jun 15 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 137.42 |
| Today’s open | 138.24 |
| Day’s range | 137.50 - 140.47 |
| Volume | 995,065 |
| Average volume (3 months) | 1,129,336 |
| Market cap | $15.3B |
Data as of 4:01pm ET, 06/24/2022
Growth & Valuation
| Earnings growth (last year) | +48.93% |
| Earnings growth (this year) | -35.20% |
| Earnings growth (next 5 years) | -10.96% |
| Revenue growth (last year) | +14.32% |
| P/E ratio | 9.3 |
| Price/Sales | 2.05 |
| Price/Book | 2.41 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LHLaboratory Corporati... | +2.87 | +1.20% |
| GHGuardant Health Inc | +1.78 | +4.00% |
| NTRANatera Inc | +2.55 | +6.56% |
| ---- |
Data as of 4:01pm ET, 06/24/2022
Financials
| Next reporting date | July 26, 2022 |
| EPS forecast (this quarter) | $2.20 |
| Annual revenue (last year) | $10.8B |
| Annual profit (last year) | $2.0B |
| Net profit margin | 18.43% |
Profile
Sector Health Services |
Industry Services to the Health Industry |
No executives to display |
Corporate headquarters Secaucus, New Jersey |
Forecasts
